Clive McCARTHY,Jonathan David HARGRAVE,Duncan Alexander HAY,Thomas Beauregard SCHOFIELD,Naomi WENT
申请号：
US16462794
公开号：
US20190315757A1
申请日:
2017.11.22
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Compounds of general formula (I) wherein R1, R2, R3, R4, R5 and X are as defined herein are inhibitors of the epithelial sodium channel (ENaC) and are useful for the treatment or prevention respiratory diseases and conditions, skin conditions and ocular conditions.
